Chen, Binghong
Wang, Mengying
Qiu, Junjun
Liao, Keman
Zhang, Wenrui
Lv, Qi
Ma, Chunhui
Qian, Zhongrun
Shi, Zhonggang
Liang, Rong
Lin, Yan
Ye, Jiazhou
Qiu, Yongming
Lin, Yingying
Funding for this research was provided by:
National Natural Science Foundation of China (81772654)
National Natural Science Foundation of China (81874215)
National Natural Science Foundation of China (82002630)
National Natural Science Foundation of China (81803007)
National Natural Science Foundation of China (82060427)
Shanghai Association for Science and Technology (201409003000)
Shanghai Association for Science and Technology (201409002400)
Shanghai Association for Science and Technology (20YF1426200)
Guangxi Key Research and Development Plan (GUIKEAB19245002)
Article History
Received: 23 February 2022
Accepted: 7 June 2022
First Online: 28 June 2022
Change Date: 4 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13046-022-02451-w
Declarations
:
: Glioma tissues and normal brain samples were in accordance with the ethical guidelines of Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University (IRB number, RA-2021–212), cervical cancer tissue samples were Obstetrics and Gynecology Hospital of Fudan University (IRB number, 2021–14), hepatocellular carcinoma tissue samples were Guangxi Medical University Cancer Hospital (IRB number, KY2020025). Written informed consents were obtained from all patients. The animal studies were approved by the Ethics Committee of School of Medicine, Shanghai Jiao Tong University (IRB number, B-2019–003).
: All authors have read and approved of its submission to this journal.
: The authors declare no competing interests.